Country: United States
Language: English
Source: NLM (National Library of Medicine)
Aceclofenac (UNII: RPK779R03H) (Aceclofenac - UNII:RPK779R03H)
United Douglas Pharm., Inc.
Aceclofenac
Aceclofenac 200 mg
ORAL
PRESCRIPTION DRUG
INDICATIONS CLANZA CR is indicated for Rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and periarthritis of scapulohumerous, lumbago, ischiadynia, pain caused by nonaticular rheutism. CONTRAINDICATIONS Patients with allergy to these drugs or other analogues (diclofenac). Patients with asthma. Like NSAIDS, acetylsalicylic acid and other drugs which inhibit prostagladin-synthesis may precipitate attacks of asthma, acute rhinitis or urticaria. Patients with active peptic ulcer. USE IN CHILDREN The dosage and indication is not established yet for children with less than 6 years old.
PACKAGE 10 Blister Packs with 10 Tablets in each Blister Pack
Export only
CLANZA CR- ACECLOFENAC TABLET, FILM COATED UNITED DOUGLAS PHARM., INC. ---------- DESCRIPTION White, oblong, film-coated tablet, engraved with "UT" on one side and "CL CR" on the other side. INDICATIONS CLANZA CR is indicated for Rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and periarthritis of scapulohumerous, lumbago, ischiadynia, pain caused by nonaticular rheutism. Dosage and Administration Adults: The recommended dose is 200 mg daily, taken as one dose (every 24 hours). However, the dose and dose frequency of CLANZA CR can be modified under the supervison of physician or pharmacist. CONTRAINDICATIONS Patients with allergy to these drugs or other analogues (diclofenac). Patients with asthma. Like NSAIDS, acetylsalicylic acid and other drugs which inhibit prostagladin-synthesis may precipitate attacks of asthma, acute rhinitis or urticaria. Patients with active peptic ulcer. CAUTIONS Patients with symptoms indicative of gastro-intestinal disorders, with a history of gastroulceration. Patients with severe hepatic impairment or cardiac or renal impairment. Patients under the medication of diuretics. Patients in recovery after surgical treatment. ADVERSE REACTIONS The majority of side effects observed have been reversible and of a minor nature and include gastro- intestinal disorders (dyspepsia, abdominal pain, nausea), rash, ruber, urticaria, symptoms of enuresis, headache, dizziness, and drowsiness. To report suspected adverse reactions, call 1-800-FDA-1088. GENERAL PRECAUTIONS Patients suffering from dizziness, vertigo, or other central nervous system disorders while taking NSAIDS should refrain from driving or handling dangerous machinery. DRUG INTERACTIONS There has been no drug interactions reported, but close monitoring of patients on combination with lithium and digoxin, oral antidiabetic agents, anticoagulants, diuretics, and other analgesics. USE IN PREGNANCY AND NURSING MOTHERS Since there is no information on the safe use of CLANZA CR during pregnancy and lactation, the use of CLANZA C Read the complete document